Eintrag weiter verarbeiten
author_facet |
Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi |
---|---|
author |
Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi |
spellingShingle |
Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi Oncology Chemotherapy in Elderly Patients with Gynecological Cancer Cancer Research Oncology General Medicine |
author_sort |
palaia, innocenza |
spelling |
Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi 0030-2414 1423-0232 S. Karger AG Cancer Research Oncology General Medicine http://dx.doi.org/10.1159/000350859 <jats:p><b><i>Objective:</i></b> The aim of this study was to determine the tolerability, safety and feasibility of chemotherapy in very elderly patients with gynecological cancers. <b><i>Methods:</i></b> We included all patients ≥75 years of age affected by endometrial, ovarian or cervical cancer treated with neoadjuvant, adjuvant or palliative chemotherapy. Data regarding age, stage of the disease, comorbidities, performance status (PS), chemotherapy regimen and dosing, toxicity, treatment delay and dose adjustments were recorded. <b><i>Results:</i></b> Forty-nine patients were included in the study. Their median age was 77.5 years. The vast majority of patients (89.8%) presented with advanced neoplastic disease. Twenty-nine of the 49 patients were treated with full-dose chemotherapy; 41% were subjected to the weekly dose. One toxic death was recorded; grade 2 anemia was reported in 8 patients, and grade 2 and 3 neutropenia was recorded in 2 and 3 patients, respectively. Sixty-one percent of the patients completed the planned treatment. <b><i>Conclusion:</i></b> Chemotherapy in very elderly patients is feasible with an acceptable toxicity profile. Careful evaluation of PS and assessment of physical and psychological health are necessary to predict tolerability of chemotherapy. A weekly schedule is better tolerated in this setting.</jats:p> Chemotherapy in Elderly Patients with Gynecological Cancer Oncology |
doi_str_mv |
10.1159/000350859 |
facet_avail |
Online |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OS8wMDAzNTA4NTk |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OS8wMDAzNTA4NTk |
institution |
DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-14 |
imprint |
S. Karger AG, 2013 |
imprint_str_mv |
S. Karger AG, 2013 |
issn |
0030-2414 1423-0232 |
issn_str_mv |
0030-2414 1423-0232 |
language |
English |
mega_collection |
S. Karger AG (CrossRef) |
match_str |
palaia2013chemotherapyinelderlypatientswithgynecologicalcancer |
publishDateSort |
2013 |
publisher |
S. Karger AG |
recordtype |
ai |
record_format |
ai |
series |
Oncology |
source_id |
49 |
title |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_unstemmed |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_full |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_fullStr |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_full_unstemmed |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_short |
Chemotherapy in Elderly Patients with Gynecological Cancer |
title_sort |
chemotherapy in elderly patients with gynecological cancer |
topic |
Cancer Research Oncology General Medicine |
url |
http://dx.doi.org/10.1159/000350859 |
publishDate |
2013 |
physical |
168-172 |
description |
<jats:p><b><i>Objective:</i></b> The aim of this study was to determine the tolerability, safety and feasibility of chemotherapy in very elderly patients with gynecological cancers. <b><i>Methods:</i></b> We included all patients ≥75 years of age affected by endometrial, ovarian or cervical cancer treated with neoadjuvant, adjuvant or palliative chemotherapy. Data regarding age, stage of the disease, comorbidities, performance status (PS), chemotherapy regimen and dosing, toxicity, treatment delay and dose adjustments were recorded. <b><i>Results:</i></b> Forty-nine patients were included in the study. Their median age was 77.5 years. The vast majority of patients (89.8%) presented with advanced neoplastic disease. Twenty-nine of the 49 patients were treated with full-dose chemotherapy; 41% were subjected to the weekly dose. One toxic death was recorded; grade 2 anemia was reported in 8 patients, and grade 2 and 3 neutropenia was recorded in 2 and 3 patients, respectively. Sixty-one percent of the patients completed the planned treatment. <b><i>Conclusion:</i></b> Chemotherapy in very elderly patients is feasible with an acceptable toxicity profile. Careful evaluation of PS and assessment of physical and psychological health are necessary to predict tolerability of chemotherapy. A weekly schedule is better tolerated in this setting.</jats:p> |
container_issue |
3 |
container_start_page |
168 |
container_title |
Oncology |
container_volume |
85 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792339005545644036 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:41:02.48Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Chemotherapy+in+Elderly+Patients+with+Gynecological+Cancer&rft.date=2013-01-01&genre=article&issn=1423-0232&volume=85&issue=3&spage=168&epage=172&pages=168-172&jtitle=Oncology&atitle=Chemotherapy+in+Elderly+Patients+with+Gynecological+Cancer&aulast=Benedetti+Panici&aufirst=Pierluigi&rft_id=info%3Adoi%2F10.1159%2F000350859&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792339005545644036 |
author | Palaia, Innocenza, Loprete, Elisa, Musella, Angela, Marchetti, Claudia, Di Donato, Violante, Bellati, Filippo, Benedetti Panici, Pierluigi |
author_facet | Palaia, Innocenza, Loprete, Elisa, Musella, Angela, Marchetti, Claudia, Di Donato, Violante, Bellati, Filippo, Benedetti Panici, Pierluigi, Palaia, Innocenza, Loprete, Elisa, Musella, Angela, Marchetti, Claudia, Di Donato, Violante, Bellati, Filippo, Benedetti Panici, Pierluigi |
author_sort | palaia, innocenza |
container_issue | 3 |
container_start_page | 168 |
container_title | Oncology |
container_volume | 85 |
description | <jats:p><b><i>Objective:</i></b> The aim of this study was to determine the tolerability, safety and feasibility of chemotherapy in very elderly patients with gynecological cancers. <b><i>Methods:</i></b> We included all patients ≥75 years of age affected by endometrial, ovarian or cervical cancer treated with neoadjuvant, adjuvant or palliative chemotherapy. Data regarding age, stage of the disease, comorbidities, performance status (PS), chemotherapy regimen and dosing, toxicity, treatment delay and dose adjustments were recorded. <b><i>Results:</i></b> Forty-nine patients were included in the study. Their median age was 77.5 years. The vast majority of patients (89.8%) presented with advanced neoplastic disease. Twenty-nine of the 49 patients were treated with full-dose chemotherapy; 41% were subjected to the weekly dose. One toxic death was recorded; grade 2 anemia was reported in 8 patients, and grade 2 and 3 neutropenia was recorded in 2 and 3 patients, respectively. Sixty-one percent of the patients completed the planned treatment. <b><i>Conclusion:</i></b> Chemotherapy in very elderly patients is feasible with an acceptable toxicity profile. Careful evaluation of PS and assessment of physical and psychological health are necessary to predict tolerability of chemotherapy. A weekly schedule is better tolerated in this setting.</jats:p> |
doi_str_mv | 10.1159/000350859 |
facet_avail | Online |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OS8wMDAzNTA4NTk |
imprint | S. Karger AG, 2013 |
imprint_str_mv | S. Karger AG, 2013 |
institution | DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-14 |
issn | 0030-2414, 1423-0232 |
issn_str_mv | 0030-2414, 1423-0232 |
language | English |
last_indexed | 2024-03-01T15:41:02.48Z |
match_str | palaia2013chemotherapyinelderlypatientswithgynecologicalcancer |
mega_collection | S. Karger AG (CrossRef) |
physical | 168-172 |
publishDate | 2013 |
publishDateSort | 2013 |
publisher | S. Karger AG |
record_format | ai |
recordtype | ai |
series | Oncology |
source_id | 49 |
spelling | Palaia, Innocenza Loprete, Elisa Musella, Angela Marchetti, Claudia Di Donato, Violante Bellati, Filippo Benedetti Panici, Pierluigi 0030-2414 1423-0232 S. Karger AG Cancer Research Oncology General Medicine http://dx.doi.org/10.1159/000350859 <jats:p><b><i>Objective:</i></b> The aim of this study was to determine the tolerability, safety and feasibility of chemotherapy in very elderly patients with gynecological cancers. <b><i>Methods:</i></b> We included all patients ≥75 years of age affected by endometrial, ovarian or cervical cancer treated with neoadjuvant, adjuvant or palliative chemotherapy. Data regarding age, stage of the disease, comorbidities, performance status (PS), chemotherapy regimen and dosing, toxicity, treatment delay and dose adjustments were recorded. <b><i>Results:</i></b> Forty-nine patients were included in the study. Their median age was 77.5 years. The vast majority of patients (89.8%) presented with advanced neoplastic disease. Twenty-nine of the 49 patients were treated with full-dose chemotherapy; 41% were subjected to the weekly dose. One toxic death was recorded; grade 2 anemia was reported in 8 patients, and grade 2 and 3 neutropenia was recorded in 2 and 3 patients, respectively. Sixty-one percent of the patients completed the planned treatment. <b><i>Conclusion:</i></b> Chemotherapy in very elderly patients is feasible with an acceptable toxicity profile. Careful evaluation of PS and assessment of physical and psychological health are necessary to predict tolerability of chemotherapy. A weekly schedule is better tolerated in this setting.</jats:p> Chemotherapy in Elderly Patients with Gynecological Cancer Oncology |
spellingShingle | Palaia, Innocenza, Loprete, Elisa, Musella, Angela, Marchetti, Claudia, Di Donato, Violante, Bellati, Filippo, Benedetti Panici, Pierluigi, Oncology, Chemotherapy in Elderly Patients with Gynecological Cancer, Cancer Research, Oncology, General Medicine |
title | Chemotherapy in Elderly Patients with Gynecological Cancer |
title_full | Chemotherapy in Elderly Patients with Gynecological Cancer |
title_fullStr | Chemotherapy in Elderly Patients with Gynecological Cancer |
title_full_unstemmed | Chemotherapy in Elderly Patients with Gynecological Cancer |
title_short | Chemotherapy in Elderly Patients with Gynecological Cancer |
title_sort | chemotherapy in elderly patients with gynecological cancer |
title_unstemmed | Chemotherapy in Elderly Patients with Gynecological Cancer |
topic | Cancer Research, Oncology, General Medicine |
url | http://dx.doi.org/10.1159/000350859 |